Clinical Trial Update: A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This entry reports an ongoing Phase 1/2 clinical trial evaluating multi-target Hi-TCR-T cell therapy for advanced hepatocellular carcinoma, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Hi-TCR-T cells (multi-target)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Advanced Hepatocellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: RECRUITING